Suboxone withdrawal is worse than heroin withdrawal.
No one has ever been able to successfully taper off Suboxone.
Tapering off Suboxone is something that’s shrouded in both mystery and myth. While the thought of stopping the medication certainly generates a bit of anxiety, the unknowns and “what ifs” are truly the drivers of fear. What will it feel like when your Suboxone dose is decreased? Will it feel like you’re in withdrawal 24/7? Will anyone help you if the taper is going too fast?
By answering the what ifs and shining a light on the unknowns, tapering off Suboxone suddenly becomes a lot less frightening. Once the fear is under control, you’re free to play a leading role in your own recovery process.
What is a Suboxone Taper?
First thing’s first; let’s talk about what a Suboxone taper is and why it’s so important. Tapering is defined as gradually discontinuing or reducing the dose of a particular drug required by a patient over a prolonged period of time. Pay close attention to those last six words: “…over a prolonged period of time.”
The process of tapering is, by definition, meant to be slow.
Suboxone is an FDA-approved medication that has changed the way opioid addiction is treated. Its unique combination of two distinctive chemical compounds – buprenorphine and naloxone – give it the ability to virtually eliminate opioid withdrawal symptoms and minimize the risk of abuse. It takes time to recover from opioid use disorders, so most patients take Suboxone for an extended period of time.
Since buprenorphine is a partial opioid agonist, it does carry a risk of dependency. Given this risk, when you’re ready to stop taking Suboxone, a supervised taper is always recommended.
Trying to quit “cold turkey” without assistance can be dangerous and cause painful withdrawal symptoms, both of which increase your odds of relapse. A supervised taper, on the other hand, significantly lowers or eliminates withdrawal symptoms and prepares your body for life beyond Suboxone.
What to Expect During a Suboxone Taper
The road to a successful Suboxone taper begins with open, honest dialogue between you and your clinician. From those conversations, you will work together to develop a plan to reduce the amount of Suboxone you take. The result is a tapering schedule that is highly individualized and focused on your personal needs instead of being focused on adherence to one specific approach.
Your dosage can be lowered a little bit at a time over several days, weeks, or even months. According to the National Alliance of Advocates for Buprenorphine Treatment (NAABT), Suboxone should generally be lowered in increments of 2 mg at a time every few days. Keep in mind, however, this progress relies on your level of dependence and individual experience. If you’re on a well-structured tapering schedule, you should only feel mild withdrawal symptoms for a few days following a reduction in dose.
If, at any point during the taper, your withdrawal symptoms or cravings become more intense, talk to your clinician. He or she can readjust your dose or slow the taper. You may need to go back to a previous dosage level in order to stabilize or increase the amount of time in between dosage reductions.
In some cases, a medication called Naltrexone may be used after you’ve tapered off Suboxone. Naltrexone is an opioid antagonist medication that works by blocking the effects of opioids. When used after the Suboxone tapering process, it offers additional anti-craving properties that can strengthen long-term sobriety. If used before the Suboxone taper is complete, however, Naltrexone can cause precipitated withdrawal.
Getting Help With Your Suboxone Taper
Some people might tell you that getting off Suboxone is impossible – that no one can handle the withdrawals or function without the medication. Thankfully, that isn’t true. With proper treatment and support, you can successfully taper off Suboxone.
10.1 million. That’s the estimated number of Americans aged 12 or older who misused opioids in 2019.
There were an estimated 75,673 opioid overdose deaths that occurred from April 2020 through April 2021.
What are we doing about these alarming statistics? The FDA has approved three drugs to treat opioid dependence. Buprenorphine – sold under the brand name Suboxone – is one of them.
Here’s how it works and what researchers have discovered.
Suboxone is an opioid partial agonist. An agonist is a chemical that triggers a response in the body. This drug only partly activates rather than fully. So its effects are weaker than substances like heroin or morphine (which are full agonists).
The drug also has a ceiling effect. This means higher doses don’t increase its effects. And, it’s long-acting, so people don’t have to take it every day.
This makes Suboxone a go-to drug for medication-assisted treatment (MAT) for opioid use disorder.
This medication can:
- Diminish the effects of physical dependency on opioids, such as withdrawal symptoms and cravings
- Increase safety (reduce the chances of overdose)
- Lower the potential for drug abuse
Ultimately, this can help people withdraw from opioids like heroin and reduce people’s use.
If it is taken as prescribed, buprenorphine is reported to be safe and effective.
How long someone takes buprenorphine varies with each case. Treatment can range from short-term to indefinite.
The US Department of Health and Human Services reports that 1.27 million Americans are now receiving medication-assisted treatment for opioid use disorder (OUD). This combines medication like buprenorphine with counseling and behavioral therapies. This creates a comprehensive treatment plan that treats the whole person.
Research has shown that this combination can successfully treat opioid use disorders and help sustain recovery.
SAMSHA states the ultimate goal of MAT is “full recovery, including the ability to live a self-directed life.”
Does It Work?
Researchers recently dug into results from drug tests to find out.
Brendan Saloner, PhD, is an associate professor at Johns Hopkins Bloomberg School of Public Health. Together with researchers from Millennium Health, he published their findings in JAMA Network Open.
These investigators analyzed 150,000 urine drug test results for OUD patients. The patients were prescribed Suboxone between 2013 and 2019. Researchers wanted to find out if the presence of Suboxone made it less likely for a person to misuse opioids.
Of their 150,000 results, 85.49 percent were positive for buprenorphine. Just under half (47.58 percent) were positive for at least one non-prescribed substance.
They discovered that patients who tested negative for prescribed buprenorphine “were significantly more likely” to test positive for other substances, compared to those who tested positive for buprenorphine.
Specifically, they found:
- Those who tested negative for buprenorphine were 10 times more likely to test positive for heroin.
- Those who tested negative for buprenorphine were seven times more likely to test positive for fentanyl.
In other words, the results indicate that if the patients stuck with their treatment, they were less likely to abuse other drugs. And, that if they stopped taking their medication, they were much more likely to turn to other drugs.
Help Is Available - Call Today
More Good News for Suboxone
Other research supports the theory that Suboxone can be an effective treatment for addiction. One meta-analysis of buprenorphine use found that doses of this medication improved retention in treatment and that high doses reduced opioid use.
And through other research, MAT has been shown to:
- Increase treatment retention
- Increase patients’ ability to remain employed
- Decrease illicit opioid use and other criminal activity among those with SUDs
- Improve patient survival
Call 844-431-5818(Who Answers?) to learn more about available treatment options near you.
Tina and Melinda are both addicted to opioids. Both of these women are paying for suboxone treatment for their opioid use disorder.
Tina has private insurance. Melinda has Medicaid coverage.
Which of these two women is more likely to get an appointment? Will providers discriminate when it comes to the method for paying for suboxone treatment?
That’s what researchers wanted to find out. So, they used “secret shoppers” to get answers.
Investigators from Baylor University’s Hankamer School of Business, RAND Corporation, and Vanderbilt University Medical Center’s Departments of Pediatrics and Health Policy collaborated on the study.
Here’s what they discovered.
It’s Hard for Anyone to Get an Appointment
Researchers made 3,420 simulated patient calls for the study. The callers identified themselves as women with Medicaid coverage or private insurance coverage. All were requesting appointments with buprenorphine providers.
Guess how many successfully landed an insurance-covered appointment? Less than half. Even with Medicaid or private insurance.
Only 45 percent of women with private insurance coverage were able to get an appointment. And just 38 percent of women with Medicaid insurance were as well.
According to the study’s lead author Michael Richards, MD, PhD, MPH, and associate professor at Baylor University in Waco:
The most striking finding is — for both callers that had private insurance and callers that had Medicaid — just how infrequently they’re able to actually leverage those insurance benefits when it comes to getting an appointment for opioid use disorder. That really speaks to the many serious and substantive access hurdles these individuals have to clear.
It’s Harder for Medicaid Patients…in Certain Areas
Previous research has shown significant differences in access to opioid use disorder treatment between patients with Medicaid versus private insurance. And this study was no different.
However, researchers discovered that these results varied based on one key factor.
Researchers found that callers with Medicaid were 11 percent less likely to get an appointment if Medicaid coverage was not common in the surrounding community.
But, as the percentage of Medicaid coverage in the local community went up, so did the number of Medicaid patients getting appointments.
In areas where Medicaid coverage was prevalent enough, the difference in access to care was insignificant.
Causes of Discrimination in Paying for Suboxone Treatment
Investigators can’t say for sure what is causing this disparity. They suspect it might be as simple as paperwork issues.
According to the study findings, providers in areas with a higher rate of Medicaid coverage may be more familiar with business processes needed to obtain payment from Medicaid for buprenorphine treatment.
But the problem is most likely multifaceted, they admit.
Whatever the issues are, researchers suggest that these findings guide future efforts. They advise, “Efforts to improve access to treatment may be best targeted to areas where Medicaid prevalence is lower.”
MAT Numbers Remain Low
In 2020, nearly 70,000 people in the United States died from opioid overdoses. Currently, buprenorphine is one of three medication-assisted treatments (MAT) approved by the World Health Organization and the FDA to treat opioid use disorder. This medication can help diminish withdrawal symptoms and cravings.
This, in turn, lowers the potential for opioid misuse.
The number of clinicians who can prescribe buprenorphine has increased 300 percent. But less than 33 percent of individuals with opioid use disorder receive any kind of MAT. Researchers hope their efforts can make a change in these numbers.
“Making it through the structural barriers to just getting into treatment for opioid use disorder is extraordinarily hard, even if you’re the most motivated person on the planet,” says study principal investigator Stephen Patrick, MD, MPH. He’s from the department of health policy at Vanderbilt University Medical Center in Nashville, Tennessee.
“We are seeing record-setting rates of overdose death, and for every overdose death, there are a slew of other hospitalizations and additional family members affected. I hope our continued research garners the attention of the public and policymakers and more clearly communicates that we must put solutions in place to break down these barriers.”
Call 844-431-5818(Who Answers?) now to learn more about the available treatment options in your area.
Medication-assisted treatment (MAT) has been a life-saving tool for so many people with opioid use disorder. In fact, the most popular medication used in MAT—Suboxone (buprenorphine/naloxone)—is approved and endorsed by the Substance Abuse and Mental Health Services Administration (SAMHSA), the Federal Drug Administration (FDA), and the National Institute on Drug Abuse (NIDA).
Thousands of people say Suboxone literally changed their lives for the better. Surely we’d never see patients facing barriers and stigma related to such a well-researched and highly-endorsed medication – not in this day and age, right?
Despite all the supporting literature and data, clinicians hear horror stories on a weekly basis – stories about pharmacies preventing access to recovery by turning away patients presenting Suboxone prescriptions.
So, what’s the deal?
What is Medication Assisted Treatment?
Medication-assisted treatment (MAT) is the use of medications, in combination with behavioral therapies, to treat opioid addiction and alcohol dependence. These medications are critical because over two million Americans live with opioid use disorder, which includes prescription opioids and illicit drugs, like heroin.
According to SAMHSA, these medications can relieve withdrawal symptoms and reduce the psychological cravings that cause chemical imbalances in the body. MAT also helps to normalize brain chemistry, block the euphoric effects of alcohol and opioids, and normalize body functions without opioid use.
There are three main types of MAT that can be prescribed by a medical provider:
- Medications for alcohol use disorder: the medications used to treat alcohol dependence include acamprosate, disulfiram, and naltrexone.
- Medications for opioid dependence (also called opioid use disorder): these medications include buprenorphine, methadone, and naltrexone
- Opioid overdose prevention medication: naloxone (commonly called its brand name, Narcan) is an opioid overdose drug that can be used to reverse the effects of opioids and save someone’s life.
How Effective is MAT?
MAT is clinically proven to be an effective treatment, with a number of positive outcomes. These medications:
- Reduce the need for detox
- Provide a comprehensive, but tailored, program combining therapy and medication that addresses most patients’ needs
- Improve patient survival
- Decrease illicit opioid use
- Decrease criminal activity
- Improve retention in treatment programs
- Increase a person’s ability to gain and sustain employment
- Improve birth outcomes among pregnant mothers with opioid use disorder.
Why Do Pharmacies Prevent Access to Recovery?
Given how effective and well-endorsed medication-assisted treatment is, you’d think that pharmacies would be happy to stock their shelves with more of the medications (and increase their bottom line). Instead, recent studies have shown that some pharmacies are refusing to stock one medication: buprenorphine.
In a recent AMERSA podcast (The Multidisciplinary Education and Research in Substance Use and Addiction), Dr. Jeffrey Bratberg and his colleagues decided to test the availability of MAT by hosting a phone-based “secret shopper.”
Bratberg, with researchers Dr. Lucas Hill, and Dr. Lindsey Loera, surveyed 800 pharmacies licensed by the state of Texas for the distribution of MAT. During their “secret shopper” experiment, Bratberg and colleagues asked pharmacies for the availability of the most prescribed MAT product, buprenorphine 8/2mg films. When medications were unavailable, researchers asked when it would come back in stock and also asked about the availability of naloxone.
The findings were pretty alarming.
Bratberg and colleagues discovered that:
- Only 34 percent of pharmacies were willing to fill one week of buprenorphine and a naloxone kit
- Chain stores were more likely than independent pharmacies to fill Suboxone prescriptions
- Prescribing just one medication (buprenorphine) didn’t make a big difference, with 42 percent agreeing to fill the prescription
- Even if the medication was out of stock, only 62 percent of pharmacies were willing to order it (and it took more than two days for Suboxone delivery)
- Some pharmacists simply refused to dispense Suboxone altogether
Digging Into Each Pharmacy’s Excuses in Preventing Access to Recovery
Researchers wanted to understand why the medication was out of stock and why pharmacists were so unwilling to prescribe an FDA-approved medication and therefore prevent access to recovery.
Bratberg and colleagues found the reasoning was simple: stigma and misconceptions.
Some pharmacists held misconceptions, believing MAT could cause euphoria or even lead to misuse. They essentially believed that, since it was an opioid, patients would use it to get high – even though that has been scientifically refuted. Other pharmacists pointed to cost issues saying that they could lose money if they had an excess supply on hand.
Critics say that the pharmacists’ perspectives are grounded in misconception and flawed arguments. Here’s why: Bratberg and colleagues pointed out in the podcast that surely all of these pharmacists had a supply of a highly addictive opioid, oxycodone, meaning the pharmacists’ reasoning was ill-founded.
Unfortunately, the lack of supply issues for MAT isn’t limited to Texas. A similar study in Kentucky found that pharmacists were terrified of DEA involvement. That reasoning does have more of a basis as wholesalers have been criticized for their part in the opioid epidemic by not reporting large orders of opioid medication.
Clearly the reasons that pharmacists prevent access to recovery are nuanced and Bratberg and colleagues say that the reasoning is complex and there needs to be a multidisciplinary approach that finds solutions and enables pharmacists to collaborate with other pharmacists, policy makers, and other MAT providers.
For information about treatment options for you or a loved one, call 844-431-5818(Who Answers?) today.
The opioid epidemic has been raging a deadly war in the United States for over two decades.
In the late 90s, Big Pharma readily reassured doctors that their patients would not become addicted to opioid pain relievers, so they started doling out prescriptions at greater rates than ever before. Unsurprisingly, this led to widespread misuse of these highly dangerous medications (e.g. natural and semi-synthetic opioids and methadone), and overdose rates began to steadily increase.
Flash forward twenty years and, and this avoidable plague has only gained momentum. In 2019 alone, over 10 million Americans misused opioids, with significant increases in overdose deaths involving synthetic opioids, particularly fentanyl. Today, synthetic opioids are now the most common drugs involved in drug overdose deaths in the United States.
While the mortality related to opioid addiction has reached epidemic levels, we have also seen a massive uptick in the number of individuals seeking treatment.
What is Medication Assisted Treatment?
Three million American citizens have had or currently suffer from opioid use disorder (OUD), and more than 500,000 in the United States are dependent on heroin.
Medication-assisted treatment (MAT) uses a combination of prescription medications, counseling, and behavioral therapies to treat opioid addiction, sustain recovery, and prevent overdose.
Medications for opioid use disorder, also known as MOUD, have been shown to reduce the risk of fatal overdoses by approximately 50%. Furthermore, studies have found that MOUD is also effective at reducing the risk of nonfatal overdoses, which can be highly traumatic and medically dangerous.
In the face of the United State’s harrowing drug epidemic, one of the primary addiction recovery methods for medication-assisted treatment is a prescription drug called Suboxone.
What is Suboxone and How Does it Work?
Since its FDA approval in 2002, Suboxone has become one of the most commonly used medication-assisted treatments for opioid addiction. Also known under the brand names Bunavail or Zubsolve, Suboxone contains two primary active substances:
- Buprenorphine is a long-acting opioid used to replace the shorter-acting, more addictive opioids that many drug users become addicted to (e.g., heroin, oxycodone, fentanyl or hydromorphone). When taken at the correct dosage, it blocks opiate receptors in the brain to provide relief from cravings and withdrawal symptoms without causing the person to feel high (euphoric) or sleepy.
- Naloxone, also known under its brand name Narcan®, is a medication used to reverse opioid overdose. When combined with buprenorphine, however, it acts as an antagonist; it enhances the opioid-blocking properties of buprenorphine while discouraging misuse. Therefore, if a drug user were to crush and snort a tablet of Suboxone, the added naloxone will block opioids from the brain’s receptors and prevent any sort of high from occurring.
When combined with supervised medical care and therapeutic treatment, Suboxone is considered a highly effective treatment for opioid use disorder.
Suboxone is an oral medication that can be administered sublingually (placed under the tongue) or buccally (between your gums and cheek) as a single daily dissolvable dose.
It’s offered in the following four dosages:
- 12 mg buprenorphine with 3 mg naloxone
- 8 mg buprenorphine with 2 mg naloxone
- 4 mg buprenorphine with 1 mg naloxone
- 2 mg buprenorphine with 0.5 mg naloxone
Most people use heroin, fentanyl, and prescription opioids multiple times a day, whereas a single daily dose of buprenorphine is long-lasting, limiting exposure to potentially lethal illicit opioids.
Common Side Effects of Suboxone
Suboxone treatment for opioid use disorder can include a number of side effects, the most severe of which are caused by Suboxone’s status as a partial opioid agonist (i.e. the presence of buprenorphine in the compound).
According to the drug manufacturer, common side effects of Suboxone can include:
- Nausea and vomiting
- Numb mouth
- Painful tongue
- Dizziness and fainting
- Problems with concentration
While treatment approaches vary depending on the addiction recovery center you or your loved one attends, there are typically four main steps in the Suboxone treatment process:
- Step 1 → New patient intake
This typically includes a medical and psychosocial evaluation, drug screen, and blood tests to ensure you’re a viable candidate for Suboxone
- Step 2 → Induction
This phase involves a transition from a user’s current opiate intake to Suboxone, with the aim of minimizing “cold turkey” withdrawal symptoms
- Step 3 → Stabilization
This phase begins after a person has discontinued or greatly reduced their drug use, no longer has cravings, and has few or no side effects. Suboxone is adjusted to the lowest dose to suppress withdrawal symptoms to allow for eventual tapering off and discontinuation of treatment
- Step 4 → Long-term maintenance
If you or a loved one suffers from a severe opioid addiction, then ongoing, medically supervised treatment of Suboxone and therapeutic support may be required. Consult with a medical professional for more details.
Get the Help You Need
Get help today at 844-431-5818(Who Answers?) to learn about treatment programs for drug and alcohol addiction.
Awareness is up. New remedies are in the works. But the stats related to the opioid epidemic are still staggering.
- Opioids were involved in nearly 50,000 overdose deaths in 2019.
- In 2019, 7 million people misused prescription pain relievers.
- In 2020, U.S. doctors wrote more than 142 million opioid prescriptions. (In some counties, they wrote enough prescriptions for every single person to have one.)
It’s a vicious cycle. Opioids are overprescribed. People take them for chronic pain. They build a tolerance. And far too many ultimately end up addicted to the drugs.
Stop the Cycle of Opioid Addiction
How does this cycle end? Perhaps by finding new remedies for pain management. Remedies that aren’t addictive.
That’s exactly what researchers like Olivier Civelli hope to do.
Civelli is a professor of pharmaceutical sciences at the UCI School of Pharmacy and Pharmaceutical Sciences and is heading up research on the use of Corydalis yanhusuo.
Is Corydalis Yanhuso an Effective Medicine to Fight Opioid Addiction?
Corydalis yanhusuo is a traditional Chinese herbal medicine. The extract of this plant, YHS, has long been used in Asian countries for the treatment of various conditions, including pain.
Western researchers are now looking to this herbal remedy for a potential solution to the opioid epidemic. And the results of their studies are promising.
- It Relieves Pain
Researchers looked at the compound’s effectiveness at alleviating pain and found the herbal medicine to be effective. Because it appears to be nonaddictive, this could be a game changer for pain management. If doctors can prescribe a remedy that is both effective and nonaddictive, we could see a reduction in opioid prescriptions that may turn the tide on the opioid epidemic.
- It Reduces Addiction
Research also shows that the extract may prove helpful in reducing or preventing addiction. Civelli’s study looked at the addictive properties of morphine in mice. The research revealed that the plant extract can help curb these addictive properties. It blocks the development of morphine tolerance and dependence. Because morphine is an opioid, this suggests it would have similar results for other drugs in the opioid family, whether synthetic or natural. It might be possible to combine this extract with methadone treatments to make them more effective, or to provide the extract to patients who are on extended opioid treatments for pain. The results? The extract may help reverse current dependence and prevent future tolerance build-up that leads to new addictions.
Creating a Tool to Prevent Addiction and Overdoses
Civelli is hopeful that this research will lead to the creation of a tool that prevents addiction and overdoses. Of course, there is a long road ahead. His study was conducted on mice, and the extract will need to be tested in human trials to confirm it effectiveness. Civelli’s goal was to get the ball rolling. He wanted to establish a concept and produce results that would compel others to take the research further, to human trials.
Researchers note that the extract is currently readily available and has proven to be safe in other uses. This could help speed along the process and development of clinical trials.
Further research is needed. For Civelli, the next step is to look into the compound in more depth. What is it about the extract that makes it helpful to prevent addiction? How exactly does it prevent drug tolerance?
And, more research is necessary to learn more about opioids. “Why is it when people take an opioid that they need to take more and more to feel the effects?” Civelli asks.
If we can discover what is going on with the interaction between these drugs and the body, we can unlock the answer to a better way to treat pain. And that could be the secret to ending the opioid epidemic.
If you or someone you love is experiencing a substance use disorder, help is available. Call 844-431-5818(Who Answers?) today.
Dave seems…different. He used to laugh easily, and he was always up for socializing. But lately, not so much. He seems moody and now he snaps at people over little things. And he’s less likely to accept invitations to get together. It’s like he’s withdrawing from me and everyone else. He’s also lost some weight. I’m not sure, but I think he’s hooked on prescription pain medication.
I started noticing changes in Dave not long after his knee injury, but that was nearly two years ago. He recently admitted that he’s still taking painkillers “just in case.” He said he’s afraid the pain might flare up again.
I want to help him, but I honestly don’t know how.
Prescription Pain Medication and Addiction
Do you have a Dave in your life? Maybe you’ve noticed signs of opioid addiction, but you’re not 100% sure what’s going on with your friend. You don’t want to sit on the sidelines while they ruin their life, but what are you supposed to do? How can you be the friend they need right now?
There’s only one place to start: talk to them.
It’s not a conversation anyone wants to have, but it needs to happen. Yes, it will be hard. Yes, it might be awkward. Yes, your friend may get mad. But avoiding or ignoring the issue will not help your friend.
The most loving thing to do is to face these challenges and talk to your friend about their possible addiction.
What Should You Say?
This might be one of the toughest conversations you ever have. It’s normal to wonder how in the world you’re supposed to bring up the topic or what you’re supposed to tell your friend.
Here are four ideas that can help your conversation:
- Take a loving approach: Always, always, always take a non-judgmental and caring approach. Yes, this is a confrontation of sorts, but don’t bring a confrontational tone to the conversation. The point isn’t to make your friend feel bad, but to help them. Make it clear that you are talking to them because you care about them.
- Use “I” statements: Try to keep the focus on how the addiction is affecting you and things you are noticing and feeling. (“I feel like we haven’t spent as much time together lately.” “I’ve been hurt lately by some of the things you’ve said.” “I’ve noticed these changes…”) When you use “I” instead of “you,” the conversation comes across as less accusatory.
- Focus on their health: Let your friend know you are concerned for their well-being. Express your worries about the effects the drug use is having on their health and life. You don’t want to come across as angry at them, just concerned about them.
- Talk about the impact: Center your talk around the effects of addiction rather than your friend’s actions. Help your friend see how addiction affects people and their loved ones. The point is to provide perspective. If they can gain a healthier perspective (without feeling judged or condemned) they are more likely to react better to your conversation.
Help Them Get Treatment for Opioid Addiction
After you bring up the topic, the next step is to point your friend in the right direction – toward help. Look through treatment options together. Ask them to bring up the potential addiction when speaking to their doctor. Help them find resources that provide the support they need.
It may also help to frame the situation as a time of transition (instead of simply calling it a change, or sobering up, or an intervention). Explain that you want to help them make a transition from dependency on prescription pain medication to making different life choices that are much healthier in the long run.
Support is available for your friend. If they are open to making changes (and remember, they have to want it), you can provide valuable resources to explore together.
- Outpatient treatment options will help your friend deal with an opioid addiction while remaining at home and work.
- Inpatient treatment is also available, and is often the most effective way for someone to conquer an addiction.
- Support groups are also key to helping your friend stay sober by providing ongoing encouragement and assistance.
And one more thing; let your friend know you’ll be there rooting for them every step of the way. Remind them they’re not alone. Believe it or not, having the encouragement of a solid support system can make all the difference in the world.
For information about treatment options for you or a loved one, call 844-431-5818(Who Answers?) today.
Images Courtesy of Pixabay
From trained therapy dogs to spoiled lap dogs, there’s no doubt our canine pals are amazing. And without the strength and love of my dog, I never could have overcome opioid addiction.
Some dogs play vital roles in assisted therapies, while others are tasked with jobs like searching for drugs, tracking the scent of a missing person, or alerting parents of a child’s oncoming seizure. More often than not, however, dogs serve as (wo)man’s best friend – loving us unconditionally and without an ounce of reservation.
I owe my life – and my sobriety – to Barley, a now 15-year-old Beagle/Schnauzer mix who renewed my belief in love, loyalty, and our possibilities. One look at his fuzzy little face and I melt.
Like most wonderful things in life, I found Barley by chance. It was literally a case of being in the right place at the right time. I was minding my own business when this scruffy little 5-week-old puppy came bounding up to me…and I instantly fell in love.
I went door-to-door in search of anyone who might know his owner. When I finally tracked this person down, the poor living conditions shocked me. I clearly remember thinking, “No wonder Barley ran away from this place.”
I could feel tears welling up in my eyes and a quickly growing sense of anger stirring in my spirit. “I don’t care what it takes, there’s no way I’m leaving him here. I’m going to rescue this dog,” I said to myself.
In chatting with the “owner,” it was clear she didn’t care about this precious pup. She said I could “have the damn mutt” if I wanted him. Before she could get out another word, I scooped Barley up, quickly walked away, and never looked back.
Once we got in my car, Barley jumped over the console and into my lap. I looked down and told him, “We’re going home, okay?” He immediately turned his head to the side, stood up on his hind legs, and laid his face on my neck. He knew he was safe. He knew he’d been rescued.
I grew up around dogs my whole life, but Barley was special. He’s the first dog I owned as an adult and, since I lived on my own, I could keep him inside. This sweet rescue dog won my heart, and I never went anywhere without him. We were absolutely inseparable…at least until drugs took over my life.
Loving (and Neglecting) My Best Friend
Like many other people, I started taking prescription opioid painkillers to treat a legitimate injury. In just a few short months, I developed a severe dependency on Vicodin. I was in over my head and, deep down inside, I knew it.
Help Is Available - Call Today
When you’re addicted to opioids, the bulk of your time is spent feeding that addiction. Every day, without fail, my only goal was to avoid withdrawal symptoms. I neglected my family, my friends, my job, my health – and my dog.
I often left Barley with my brother for two and three days at a time. Before I started abusing opioids, I would have been beside myself if I hadn’t seen my best buddy for a whole day, much less two or three. When I wasn’t dropping Barley off with family members, I was sleeping, working, or out looking for more pills.
I’d drive around with my poor dog in the passenger seat, riding shotgun while I was on a mission to find more drugs. And on these Vicodin-fueled trips, Barley would sit to my right, his head proudly stuck out the window, ears flapping in the wind, and nose working overtime to process scents in the air. He was so happy and content to be with me. But I was too sick to see it and too lost in addiction to care.
What an absolute waste of precious time.
Breaking My Opioid Addiction
My addiction to opioid painkillers spanned the better part of two years. And then one day, quite out of the blue, I decided it was time to get sober. I found an outpatient addiction treatment program that offered the specific therapies I needed, called them up, and made my first appointment. It’s the best decision I ever made for myself.
I took my recovery seriously and gave it everything I had to give. I understood that, if I didn’t break the shackles of my addiction, I’d never make it out alive. I honestly couldn’t bear the thought of relapsing.
After a few months went by, my body was rid of the drugs and the withdrawal sickness. Physically I felt wonderful; mentally I was a mess. I just felt so lost and incredibly unsure of my place in the world.
No matter where I went, I was sure that everyone saw me and knew my dirty little secret. I was an addict in recovery, and I was scared out of my mind.
Why would anyone want to be my friend? How could I ever make up for all the pain I caused? Who would ever want to love someone like me?
And then the answer licked me in the face.
My dog, my Barley, never ever left my side. My precious dog loved me no matter what kind of disease I was fighting. Every day that I didn’t have the self-esteem or courage to show my face to the world, Barley could sense it. And he would bounce around, pawing and prodding me to take him outside. He’d take his wet nose and push me, quite literally, out of the bed.
Looking in his eyes, I knew exactly what he was trying to say:
“Look mom, I love you. I’m here for you. Now get your butt up, stop feeling sorry for yourself, and let’s go live this day to the fullest.”
Embracing Life After Opioid Addiction
Believe it or not, after a few weeks of simply walking my dog and being present in the moment, my whole demeanor changed. And the miracle is that, once I began to go outside, soak up the sunshine, and breathe in the fresh air, I wanted more out of life – more out of myself.
It no longer satisfied me to hide in the house and punish myself for the mistakes of my past. I still had the support of family and real friends. I stopped worrying about things that didn’t matter. I let go of the fear and chose to embrace every day.
For too many years, I walked around believing I rescued Barley. The truth is he rescued me as much as I rescued him.
I am alive and sober today, and I owe it all to my best friend. My Barley.
Images courtesy of Pixabay and Nikki Seay